secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

header-component

products

config

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

container

cengage:galethorndikeseo

footer-menu-component

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

single-column

zone2

Account Information

bundle-connector

mega-menu

Browse by Institution Type

Browse by Product Type

Products

Support

footer-legal-menu-component

zone3

secondary-account-menu

zone1

footer

gale-footer

secondary-primary-menu

FIND YOUR REP

support-order-2

Profile

Orders

Wish List

Fast Order Entry

My Account

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

About Us

Blogs

Press Center

Events

News

Careers

Our Company

Request a Trial

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Partnerships

Contact Us

header

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

footer-legal-menu

Terms of use

Privacy

footer-social-menu-component

DEBATNG MOD MEDCL TECH: PLTCS SFTY EFFCTVNSS PTNT ACCSS

Public Policy

Law, Government & Politics

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

<P>Medical technologies often promise to extend and improve quality of life but come with many questions: Are they safe and effective? Are they worth the cost? When should they be allowed on the market, and when should Medicare, Medicaid, and private insurance companies be required to pay for drugs, devices, and diagnostic tests? Using case studies of disputes about the value of mammography screening; genetic testing for disease risk; brain imaging technologies to detect biomarkers associated with Alzheimer's disease; cell-based therapies; and new, expensive drugs, this book illustrates how scientific disagreements about what is good evidence of safety and effectiveness are often swept up in partisan fights over health care reform and battles among insurance and health care companies, physicians, and patient advocates. It reveals stakeholders' differing values and interests and clarifies the nature and complexity of past and current policy disagreements and their effects on patients.</P>

Debating Modern Medical Technologies

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Contents.
Acknowledgments.
1: Evidence, Politics, and Medical Care Technology.
2: Evolving Public- and Private-Payer Approaches to Evidence and Health Technology Assessment.
3: Mammography Screening: Vested Interests and Polarization.
4: When Medicare Said No for Amyloid PET Imaging.
5: Placing a Value on Cure: Lessons from the New Generation of Hepatitis C Drugs.
6: Avastin and the Politics of Accelerated Approval.
7: The Path to the Clinic for Stem Cell and Other Regenerative Medicine Interventions.
8: Conclusion: The 21st Century Cures Act and the Future of Health Technology Assessment.
Notes.
Bibliography.
Index.
About the Authors.

Debating Modern Medical Technologies.css-1p8rvzy{position:absolute;padding-left:8px;}

Debating Modern Medical Technologies